Suppression of mammary tumors by oral administration of 1-(2- tetrahydrofuryl)-5-fluorouracil in combination with uracil in SHN virgin mice

S. Sakamoto, M. Mizuno, H. Kudo, S. Suzuki, N. Kasahara, Y. Sugiura, T. Mori, H. Nagasawa

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic oral administration of 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil suppressed not only de novo but also salvage pathways for pyrimidine nucleotide synthesis, and reduced mammary tumorigenesis and tumor growth in SHN virgin mice, which have a high potential for the incidence of mammary tumors.

Original languageEnglish (US)
Pages (from-to)651-655
Number of pages5
JournalAnti-Cancer Drugs
Volume4
Issue number6
DOIs
StatePublished - 1993

Keywords

  • 5-fluorouracil
  • DNA synthesizing enzyme
  • SHN virgin mouse
  • mouse mammary tumor

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research

Fingerprint

Dive into the research topics of 'Suppression of mammary tumors by oral administration of 1-(2- tetrahydrofuryl)-5-fluorouracil in combination with uracil in SHN virgin mice'. Together they form a unique fingerprint.

Cite this